How is the Pliant Therapeutics Inc today?

The Pliant Therapeutics Inc today is trading in the green, up by 0.75% at 1.34.

What is Pliant Therapeutics Inc Annual Net Profit?

Pliant Therapeutics Inc Annual Net Profit fell 30.35% in the last year to $210.3 M. Its sector's average net profit growth for the last fiscal year was -11.13%.

What is Pliant Therapeutics Inc Price to Earning Ratio?

Pliant Therapeutics Inc Price to Earning Ratio is -0.37, which is negative.

What is Pliant Therapeutics Inc Stock Price?

Pliant Therapeutics Inc Stock Price fell 90.55% and underperformed its sector by 102.09% in the past year.

What is Pliant Therapeutics Inc Quarterly Net profit?

Pliant Therapeutics Inc Quarterly Net profit fell 19.62% YoY to $56.17 M. Its sector's average net profit growth YoY for the quarter was -212.2%.

What is Pliant Therapeutics Inc Debt to Equity Ratio?

Pliant Therapeutics Inc Debt to Equity Ratio of 0.2 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

What is Pliant Therapeutics Inc Return on Equity(ROE)?

Pliant Therapeutics Inc Return on Equity(ROE) for the last financial year was -54.09%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is Pliant Therapeutics Inc Mutual Fund Holding?

Pliant Therapeutics Inc Mutual Fund Holding decreased by 31.09% in the last quarter to 30.83.

What is Pliant Therapeutics Inc Interest Coverage Ratio?

Pliant Therapeutics Inc Interest Coverage Ratio is -68.54, lesser than one. This means that it is unable to pay interests with its earnings (EBIT).

What is Pliant Therapeutics Inc Institutional Holding?

Pliant Therapeutics Inc Institutional Holding decreased by 1% in the last quarter to 108.7.

Pliant Therapeutics Inc XNAS: PLRX

Pliant Therapeutics Inc Live Share Price Today, Share Analysis and Chart

Name: Pliant Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Pliant Therapeutics Inc
Rating: 1.06183325
Author: Trendlyne DVM scores

about

Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small m...

1.34 0.01 (0.75%)

91.68% Fall from 52W High

712.3K XNAS Volume

XNAS 22 May, 2025 5:30 PM (EDT)

Not Eligible

-

Expensive Valuation

15.3 / 100

Technically Bearish

27.1 / 100

40

1Yr Price target upside is 2899%

11 analysts

Pliant Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Pliant Therapeutics Inc FAQ

How is Pliant Therapeutics Inc today?

Pliant Therapeutics Inc today is trading in the green, and is up by 0.75% at 1.34.

How has Pliant Therapeutics Inc performed historically?

Pliant Therapeutics Inc is currently trading up 0.75% on an intraday basis. In the past week the stock fell -2.19%. stock has been down -56.49% in the past quarter and fell -90.55% in the past year. You can view this in the overview section.